In order to control the worldwide epidemic of coronavirus (COD-19) and prevent deaths from it, some special help will have to be resorted to. Thus, artificial intelligence is very important in the field of science. There is a role, but there is a record of what it has done to eradicate the corona virus. Can artificial intelligence help find a cure for this dangerous disease?
Numerous companies are working to solve the problem. Oxford-based company Accentia, which first tested the drug discovered by artificial intelligence on humans, studied 15,000 drugs at the Scripps Research Institute in California. Helix, a Cambridge company founded by Dr. David Brown, the creator of Viagra, has turned to artificial intelligence systems to find cures for rare diseases. Now their goal is to find a cure for corona.
Dr. Brown says that artificial intelligence is proving to be fast in introducing new drugs. According to Dr. Brown, it has taken several weeks to compile the required data and some new information has been received. Therefore, we have a large amount of data. The algorithm has been run on Easter and we will have the results in the next few days
Helix says that in light of this information, a list of possible drugs will be compiled by this month, followed by clinical trials in laboratories. What can be done is to develop a completely new drug but it will have to wait for many years for its safe use and the second is to re-develop the existing drug with a new purpose.
But on the one hand, Dr. Brown says that it is not possible to say with certainty whether this epidemic can be cured with a single drug or not. According to him, artificial intelligence is one of the strongest ways to get a conceivable medicine. But the basic requirement for this is high quality, big and clear data.
There is now a need to gather the data sources involved in the discovery of these proportional drugs, so that artificial intelligence researchers can discover the cure for Covide-19 as soon as possible using their new machine learning techniques. The university's Bar Abbasi Laboratory, Harvard Medical School, Stanford Network Science Institute and biotech startup Schaefer Medicine are working together to find a drug that can be re-formulated as soon as possible to treat covide 19.
According to Schaefer's chief executive, Alif Saleh, it usually takes a year for all of them to work together on paperwork, but a series of zoom calls begin with people who have the ability to get things done. This whole process can be speeded up. The work that has been done in the last few weeks usually takes half a year, but everyone is working hard day and night to focus on the research and the amazing results are beginning to emerge.
Research has shown that the virus can invade brain cells, causing some people to lose their sense of taste or smell. Schaefer Madison linked artificial intelligence to something they developed.Medicine is called Network medicine. Experts say that it is a way of looking at a disease through a complex interrelationship between molecular components. Caused by malfunction. Nature is not so simple.
Rather, it is the result of a collision between several proteins. Using network medicine, artificial intelligence and a fusion of the two, the consortium has identified 81 possible drugs that could be helpful. According to him, artificial intelligence can work much better, not only to improve the order, but also to look at the free information that may not have passed through the eyes of network medicine. But artificial intelligence alone cannot do this, for all three Procedure is required.
Professor Darzi says global policymakers need to bring together major pharmaceutical companies, academics and research institutes to work together using their data sources. There can be no better opportunity to share drug discovery statistics and important things with each other.
0 Comments